Product Information

CLARITHROMYCIN 250 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3485 per EA under NDC 57237004460. Its NADAC has been published 654 times since Apr 9, 2014.

FDA first approved this application on Jul 25, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLARITHROMYCIN 250 MG TABLET

Clarithromycin
$0.3485per EA

Strength

250 mg/1

NDC

57237004460

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLARITHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065489

FDA Approved

7/25/2012

TE Code

AB

On Market Since

7/25/2012

Pharmacological Classes

Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
Macrolide Antimicrobial
Macrolides
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CLARITHROMYCIN 250 MG TABLET has been published 654 times since Apr 9, 2014, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3485 per EA
All-time high$3.3001 (Apr 16, 2014)
All-time low$0.3332 (Nov 20, 2024)
52-week high$0.4183
52-week low$0.3421
Median price$0.6241
Average price$0.9928
Largest weekly change+73.4% (Jan 18, 2023)
Weeks tracked654
Tracking sinceApr 9, 2014

Price History

1W

-10.4%

1M

-11.5%

3M

-3.9%

6M

-6.0%

1Y

-16.7%

3Y

-25.7%

5Y

-1.0%

All

-89.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLARITHROMYCIN 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN 250 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.3485 per EA (NDC 57237004460), effective Nov 18, 2026.

How has the price of CLARITHROMYCIN 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLARITHROMYCIN 250 MG TABLET has declined 89.4%. It has been tracked across 654 weekly CMS publications since Apr 9, 2014.

What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN 250 MG TABLET?

Since Apr 9, 2014, the NADAC for CLARITHROMYCIN 250 MG TABLET has ranged from a low of $0.3332 (Nov 20, 2024) to a high of $3.3001 (Apr 16, 2014), with a median of $0.6241 per EA.

Are there cheaper alternatives to CLARITHROMYCIN 250 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLARITHROMYCIN 250 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLARITHROMYCIN 250 MG TABLET?

CLARITHROMYCIN 250 MG TABLET (NDC 57237004460) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.